Research is being conducted on the gut microbiome and its associated metabolic pathways in various patient groups, including those with immunodeficiency, metabolic disorders, and cancer. The studies aim to identify distinct properties and associations in the gut microbiome of these patients, with some focusing on the impact of specific factors such as dietary composition or exposure to certain medications. The findings may reveal key connections between gut microbiota, metabolites, and disease outcomes in different populations.